Social Media Content Creators Fueling Parallel Trade for Unapproved Weight-Loss Drug

A shadow market for unlicensed slimming medications is being driven by TikTok fitness influencers and vendors on communication apps, according to new investigations.

Experimental Drug Acquiring Popularity Via Social Media

The experimental drug, which remains in research studies, is being advertised by social media influencers for its alleged fat-burning properties. Viewers are urged to contact these accounts directly for source information, while also receiving discount codes.

Thriving Trade on Social Networks

Separately, a flourishing trade exists on Telegram, where groups with thousands of members share “before and after” images, injection guides and assertions of next-day UK delivery. Sellers market the drug there before redirecting customers to other platforms for purchases.

Understanding The Experimental Drug

This medication is an experimental injection created by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – GLP-1, GIP and glucagon. Preliminary studies indicate it could assist individuals reduce up to 25% of their total weight. Nicknamed the “triple G”, the substance is being promoted digitally as the successor to Ozempic.

Medical Experts Express Worries

Nevertheless, doctors and chemists have warned that the sale of what remains an unapproved medication in the United Kingdom is a cause for concern and could lead to users administering products of unknown origin.

Several professionals stated the demand for retatrutide could be linked to the rising price of licensed weight loss products such as Mounjaro.

Legal Status and Enforcement

Selling retatrutide on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unapproved drug that must not be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.

Some influencers try to sidestep the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but advertising and distribution can still breach pharmaceutical, advertising, and customer laws, risking fines, prosecution or imprisonment.

Service Response and Content Elimination

According to TikTok, the service has taken down problematic material and prohibited associated hashtags and query recommendations. The organization stated it was dedicated to keeping the service secure and investing in strengthening compliance measures.

Digital Trading Operations

Investigations also found communities with up to nine thousand members marketing retatrutide using Telegram's built-in search feature, which functions like a public directory. Typing “retatrutide” instantly displays channels with thousands of users, populated with images of weight loss, glowing reviews and detailed guides for mixing or injecting at home.

After minutes of joining one group, a seller shared contact information, where most purchases occur. The vendor sent an instruction manual and guaranteed shipping within 48 hours. When questioned whether the product was genuine, one seller responded: “You can’t be sure.” Another shared a photo of a alleged testing documentation. Not one inquired about body mass, medical conditions or past usage.

Item Details and Pricing

Within these groups, messages show dark colored parcels with postal service stickers, claiming to contain new batches. One communication read: “It took eight of us to load them this morning.”

Buyers can select between powder vials, mixed at residence with purified liquid, or pre-filled injectors usually priced at 160 pounds for 20mg. When asked how long a injector should last, sellers give contradictory answers varying between a several days to “depends on your body”.

Platform Moderation and Safety Actions

A spokesperson for the messaging service stated it actively monitored harmful material on its platform including material that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“People are injecting materials they cannot confirm. Even if the research behind retatrutide is sound, these online products may not include what they claim,” said a pharmacy expert, the head of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor linked the surge in demand to current cost increases for approved slimming drugs such as Mounjaro. “With prices rising, individuals are using online platforms. But counterfeit injections are highly dangerous. You cannot know what’s contained or whether the environment they were made in was clean,” she explained.

Her team has already seen individuals harmed by self-injection from unverified sources. “We understand the disappointment, but purchasing from Telegram or communication platforms is gambling with your health,” stated Wyllie. “These materials could be contaminated or improperly measured.”

Manufacturer Statement

A spokesperson from Eli Lilly said the substance was in phase 3 research studies and had not been reviewed or approved by any government authority anywhere in the world. “Consequently at this time no one can market [it] for human use,” they explained, noting that any product “misleadingly claiming itself as a company experimental substance not yet approved … may subject patients to possibly serious medical dangers”.

Lisa Francis
Lisa Francis

A technology journalist and business analyst with over a decade of experience covering digital transformation and startup ecosystems across Europe.